Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDC-002 Drug-Drug Interaction Study in Healthy Volunteers
NCT06090474Phase 1Completed
- Sponsor
- DR.NOAH BIOTECH
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of donepezil and acetylcysteine in stroke, sponsored by DR.NOAH BIOTECH. Primary endpoints: Adverse events, Area Under the Curve at steady state over dosing interval at Day 36 and 1 more. Started Jan 2023; status: completed.
02
Drugs
donepezilacetylcysteine
03
Conditions
stroke
Beyond the preview
Go deeper on NCT06090474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06090474.